The success of crystallography in determining atomic resolution structures of thousands of diverse proteins has revolutionized biology. Membrane proteins, a large and medically important class, have not kept pace with the advances in methodology that have made this revolution possible. The reason for this is that, unlike soluble proteins, membrane proteins must enter into the lipid bilayer during their biogenesis. This additional level of complexity has prevented membrane proteins from being obtained at levels similar to soluble proteins. For structural biology to be successful, a membrane protein must be overexpressed. The problem is that with current technology this has been impossible for the majority of membrane proteins;therefore, few structures are determined and each is extremely expensive. This proposal aims to solve this problem by proving the following hypothesis: The limiting factor in membrane protein overexpression is their need to be targeted and inserted into the membrane. Membrane proteins are recognized by N-terminal signals that must be accurately read to appropriately deliver the protein for insertion into the membrane via the translocation machinery. Our goal will be to develop a universal signal that will allow us to overcome this intrinsic rate- limiting step. We will accomplish this by systematically testing every aspect of membrane protein targeting. With this comprehensive approach, we will derive biological insight;moreover, we will dramatically improve the number of membrane protein targets available for crystallization. The effect will be to improve the success rate of crystallization trials dramatically reducing the cost of solving a membrane protein structure. The hope is to open up a new revolution in membrane structure determination that will allow us to address a wealth of important medical problems. My laboratory is uniquely positioned to lead this new revolution. ) Public Health Relevance: Atomic resolution structures prov

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
NIH Director’s Pioneer Award (NDPA) (DP1)
Project #
5DP1GM105385-03
Application #
8548382
Study Section
Special Emphasis Panel (ZGM1-NDPA-A (01))
Program Officer
Smith, Ward
Project Start
2011-09-30
Project End
2016-07-31
Budget Start
2013-08-01
Budget End
2014-07-31
Support Year
3
Fiscal Year
2013
Total Cost
$795,400
Indirect Cost
$310,400
Name
California Institute of Technology
Department
Chemistry
Type
Schools of Engineering
DUNS #
009584210
City
Pasadena
State
CA
Country
United States
Zip Code
91125
Saladi, Shyam M; Javed, Nauman; Müller, Axel et al. (2018) A statistical model for improved membrane protein expression using sequence-derived features. J Biol Chem 293:4913-4927
Niesen, Michiel J M; Marshall, Stephen S; Miller 3rd, Thomas F et al. (2017) Improving membrane protein expression by optimizing integration efficiency. J Biol Chem 292:19537-19545
Marshall, Stephen S; Niesen, Michiel J M; Müller, Axel et al. (2016) A Link between Integral Membrane Protein Expression and Simulated Integration Efficiency. Cell Rep 16:2169-2177
Jang, Kyoung-Soon; Nani, Roger R; Kalli, Anastasia et al. (2015) A cationic cysteine-hydrazide as an enrichment tool for the mass spectrometric characterization of bacterial free oligosaccharides. Anal Bioanal Chem 407:6181-90
Mitachi, Katsuhiko; Siricilla, Shajila; Klaic, Lada et al. (2015) Chemoenzymatic syntheses of water-soluble lipid I fluorescent probes. Tetrahedron Lett 56:3441-3446
Jang, Kyoung-Soon; Sweredoski, Michael J; Graham, Robert L J et al. (2014) Comprehensive proteomic profiling of outer membrane vesicles from Campylobacter jejuni. J Proteomics 98:90-8
Ramasamy, Sureshkumar; Abrol, Ravinder; Suloway, Christian J M et al. (2013) The glove-like structure of the conserved membrane protein TatC provides insight into signal sequence recognition in twin-arginine translocation. Structure 21:777-88
Tanaka, Shiho; Clemons Jr, William M (2012) Minimal requirements for inhibition of MraY by lysis protein E from bacteriophage ?X174. Mol Microbiol 85:975-85